Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine to prevent hypotension during remimazolam anesthesia induction
ChiCTR2400082181Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University Ethical Committee
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in hypotension (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University Ethical Committee. Primary endpoint: Incidence of hypotension after anesthesia induction. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
hypotension
Beyond the preview
Go deeper on ChiCTR2400082181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082181.